Project Grant HT94252410134
Award Date
7/1/24
Completion Date
6/30/26
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
The federal Project Grant award of $707,436.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on May 1, 2025, supports research to be conducted by the Albert Einstein College of Medicine in Bronx, NY to investigate "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS TREATMENTS". The research aims to advance scientific understanding and develop innovative medical solutions...
The U.S. Department of the Army Medical Command awarded a $462,000 project grant to the Albert Einstein College of Medicine in Bronx, New York, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from January 1, 2025 to December 31, 2026, supports the college's research project titled "Proteomics of Vascular Wall Aging." The project aims to conduct advanced biomedical research to transform healthcare for military...
The U.S. Department of Defense's Defense Health Agency awarded a $672,000 Project Grant to the Albert Einstein College of Medicine in Bronx, NY to support the "MRNA TRANSLATION AND IMMUNE RECOGNITION IN MYC-DRIVEN LYMPHOMA" research project. This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research initiatives to transform healthcare for military service members and the broader public. The 2-year project,...
The Albert Einstein College of Medicine, a private non-profit educational institution in the Bronx, New York, has been awarded a $672,000 Project Grant by the Defense Health Agency, a component of the Department of Defense. The grant, which runs from March 1, 2024 to February 29, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420) and will support research on "Clonal Hematopoiesis as a Driver of Therapeutic Resistance and Metastatic Relapse in Breast...
The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military...
The Albert Einstein College of Medicine has been awarded a $168,000 Project Grant from the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the role of alpha1-3/4 fucosyltransferases-mediated E-selectin function in the bone metastasis of prostate cancer. The project aims to advance scientific understanding and develop new treatment approaches for this form of cancer that disproportionately affects military service members...
The U.S. Department of Defense's Defense Health Agency awarded a $3,292,001 Project Grant to the Albert Einstein College of Medicine in Bronx, New York under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports a 4-year research project to produce cultured red blood cells for sickle cell disease patient support, with a project period from June 1, 2025 to May 31, 2029. As a prominent non-profit research institution, the Albert Einstein College of...
The Albert Einstein College of Medicine was awarded a $1,260,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into "A NOVEL IMMUNE CHECKPOINT PATHWAY IN HUMAN PROSTATE CANCER" from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
The Albert Einstein College of Medicine was awarded a $505,122 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through February 2024 to decipher the stemness code for breast cancer metastasis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health...